Igc Pharma Inc
(IGC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2015 | 03-2014 | 03-2013 | 03-2012 | 03-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 825 | 1,027 | 1,064 | 563 | 1,583 |
| Receivables | 993 | 566 | 1,067 | 1,642 | 3,312 |
| Inventories | 710 | 612 | 407 | 388 | 134 |
| Other current assets | 0 | 0 | 0 | 42 | 42 |
| TOTAL | $4,478 | $3,759 | $4,269 | $5,220 | $6,545 |
| Non-Current Assets | |||||
| PPE Net | 7,784 | 7,587 | 8,184 | 8,492 | 1,232 |
| Investments And Advances | 6,028 | 5,141 | 5,193 | 5,747 | 7,307 |
| Intangibles | 1,289 | 468 | 592 | 4,804 | 411 |
| Other Non-Current Assets | 753 | 780 | 1,015 | 998 | 2,668 |
| TOTAL | $15,854 | $13,976 | $14,984 | $20,040 | $11,617 |
| Total Assets | $20,332 | $17,734 | $19,253 | $25,260 | $18,162 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,354 | 425 | 447 | 432 | 901 |
| Accounts payable and accrued liabilities | 175 | 133 | 601 | 648 | 1,312 |
| Accrued Expenses | 422 | 419 | 467 | 917 | 349 |
| Other current liabilities | 497 | 54 | 311 | 563 | 95 |
| TOTAL | $2,448 | $1,031 | $1,825 | $4,496 | $6,577 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,124 | 1,800 | 1,800 | N/A | N/A |
| Other Non-Current Liabilities | 1,079 | 778 | 669 | 4,373 | 5,061 |
| TOTAL | $3,134 | $2,558 | $2,453 | $4,948 | $4,292 |
| Total Liabilities | $5,582 | $3,589 | $4,278 | $9,444 | $10,869 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,860 | 11,380 | 6,980 | 6,006 | 1,976 |
| Common Shares | 2 | 1 | 1 | 6 | 2 |
| Retained earnings | -47,334 | -42,720 | -39,697 | -37,445 | -29,693 |
| Other shareholders' equity | -1,398 | -1,499 | -1,483 | -1,567 | -1,876 |
| TOTAL | $14,750 | $14,145 | $14,974 | $15,816 | $7,293 |
| Total Liabilities And Equity | $20,332 | $17,734 | $19,253 | $25,260 | $18,162 |